339PManagement of abemaciclib associated adverse events in patients with hormone receptor positive (HR+), HER2- advanced breast cancer: Analysis of the MONARCH trials. (23rd October 2018) - Rugo, H S; Tolaney, S M; Huober, J; Toi, M; André, V; Barriga, S; Forrester, T; Sledge, G W; Goetz, M P